As Novartis Ag (NVS) Shares Rose, John G Ullman & Associates INC Has Lifted Stake

June 19, 2017 - By Clifton Ray

John G Ullman & Associates Inc increased its stake in Novartis Ag (NVS) by 95.52% based on its latest 2016Q4 regulatory filing with the SEC. John G Ullman & Associates Inc bought 51,280 shares as the company’s stock rose 4.17% with the market. The institutional investor held 104,964 shares of the major pharmaceuticals company at the end of 2016Q4, valued at $7.65 million, up from 53,684 at the end of the previous reported quarter. John G Ullman & Associates Inc who had been investing in Novartis Ag for a number of months, seems to be bullish on the $211.34 billion market cap company. The stock rose 0.35% or $0.28 reaching $81.11 per share. About 209,326 shares traded. Novartis AG (ADR) (NYSE:NVS) has risen 7.67% since June 19, 2016 and is uptrending. It has underperformed by 9.03% the S&P500.

Novartis AG (ADR) (NYSE:NVS) Ratings Coverage

Among 14 analysts covering Novartis Ag (NYSE:NVS), 4 have Buy rating, 2 Sell and 8 Hold. Therefore 29% are positive. Novartis Ag had 22 analyst reports since July 28, 2015 according to SRatingsIntel. The firm has “Buy” rating by Argus Research given on Thursday, November 10. Leerink Swann downgraded Novartis AG (ADR) (NYSE:NVS) rating on Wednesday, March 23. Leerink Swann has “Market Perform” rating and $85 target. The stock of Novartis AG (ADR) (NYSE:NVS) has “Neutral” rating given on Tuesday, March 29 by Citigroup. The stock of Novartis AG (ADR) (NYSE:NVS) has “Neutral” rating given on Thursday, March 23 by Goldman Sachs. The rating was downgraded by JP Morgan to “Neutral” on Tuesday, January 3. The stock of Novartis AG (ADR) (NYSE:NVS) has “Neutral” rating given on Wednesday, January 11 by Credit Suisse. Morgan Stanley downgraded the shares of NVS in report on Tuesday, April 12 to “Underperform” rating. Chardan Capital Markets initiated the stock with “Buy” rating in Tuesday, September 20 report. On Friday, June 16 the stock rating was maintained by J P Morgan Chase Co with “Neutral”. The firm earned “Neutral” rating on Friday, April 1 by UBS.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.